Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

67%(2 trials)

Phase Distribution

Ph phase_3

25%

Ph phase_2

50%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

2(50.0%)

Phase 3Large-scale testing

1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (25.0%)

Phase 22 (50.0%)

Phase 31 (25.0%)

Trials by Status

completed375%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingphase_2

Tirzepatide for Alcohol Use Disorder

NCT06994338

completedphase_1

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

NCT00585650

completedphase_2

Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia

NCT02604186

completedphase_3

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

NCT00264537

Clinical Trials (4)

Showing 4 of 4 trials

NCT06994338Phase 2

Tirzepatide for Alcohol Use Disorder

Recruiting

NCT00585650Phase 1

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

Completed

NCT02604186Phase 2

Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia

Completed

NCT00264537Phase 3

A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4